FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug 30, 2018--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that John F. Milligan, PhD, Gilead’s President and Chief Executive Officer; Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer; and John McHutchison, AO, MD, Gilead’s Chief Scientific Officer and Head of Research & Development, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 12 at 11:05 a.m. Eastern Time.

The audio portion of the fireside chat will be accessible live through the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180830005581/en/

CONTACT: Gilead Sciences, Inc.

Sung Lee, 650-524-7792

Investor Relations

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY HOSPITALS PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Gilead Sciences, Inc.

Copyright Business Wire 2018.

PUB: 08/30/2018 04:01 PM/DISC: 08/30/2018 04:01 PM

http://www.businesswire.com/news/home/20180830005581/en